Rifapentine
1 NDC across 1 manufacturer|0 Generic,1 Brand
Rifapentine is used to treat latent tuberculosis and pulmonary tuberculosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 22, 1998, and the first generic was approved Jun 23, 2026. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $552K on Rifapentine across 2,888 claims for 1,697 beneficiaries.
Rifapentine is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $4.83 to $4.83 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$4.83 – $4.83
per EA
7d Activity
avg +0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sanofi-Aventis U.S. LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing RIFAPENTINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PRIFTIN 150 MG TABLET | $4.8280 per EA | +0.06% |
Frequently Asked Questions
What is Rifapentine used to treat?
Rifapentine is used to treat latent tuberculosis and pulmonary tuberculosis, per the National Library of Medicine's MED-RT classification.
When did Rifapentine become available as a generic?
FDA approved the first generic Rifapentine (ANDA) on Jun 23, 2026. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Rifapentine?
In 2024, Medicare Part D spent $552K on Rifapentine across 2,888 claims for 1,697 beneficiaries.
How many Rifapentine products are on the market?
The Rifapentine drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Rifapentine?
NADAC reference prices for Rifapentine range from $4.8280 to $4.8280 per EA.
Which manufacturers make Rifapentine?
1 manufacturer lists Rifapentine in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (1).
How has the price of Rifapentine changed recently?
Over the past 7 days, 1 Rifapentine NDC rose and 0 fell, with a market-wide average change of +0.1%.